Keyphrases
Amyotrophic Lateral Sclerosis
100%
Microbial Composition
100%
Prospective Longitudinal Study
100%
Gut Microbiota Composition
60%
Gut Microbiota
40%
Microbiota
40%
ALSFRS-R
40%
Microbial Groups
40%
Probiotic Treatment
40%
Italy
20%
Control Subjects
20%
Quantitative PCR
20%
Placebo
20%
Disease Progression
20%
Health Status
20%
Pro-inflammatory Activity
20%
Disease Course
20%
Next-generation Sequencing
20%
University Hospital
20%
Trial Registration
20%
Operational Taxonomic Units
20%
Probiotic Supplementation
20%
Disability Status
20%
Ethics Committees
20%
Biodiversity
20%
16S rRNA Gene
20%
Bacteroidetes
20%
Cyanobacteria
20%
Polymerase Chain Reaction-denaturing Gradient Gel Electrophoresis (PCR-DGGE)
20%
Composition Change
20%
Microbial Profile
20%
Intestinal Microbiota
20%
Stool Samples
20%
V3-V4 Region
20%
Gut Diseases
20%
Microbial Strategies
20%
Medicine and Dentistry
Amyotrophic Lateral Sclerosis
100%
Gut Microbiota
80%
Probiotics
60%
Gut
40%
Diseases
40%
Biological Marker
20%
Placebo
20%
Clinical Study
20%
Disease Exacerbation
20%
Body Mass Index
20%
Next Generation Sequencing
20%
Supplementation
20%
Health Status
20%
Real-Time Polymerase Chain Reaction
20%
Cyanobacteria
20%
DNA 16S
20%
Operational Taxonomic Unit
20%
Denaturing Gradient Gel Electrophoresis
20%
Bacteroidetes
20%
Biodiversity
20%
Immunology and Microbiology
Microflora
100%
Intestine Flora
100%
Probiotic
60%
Next Generation Sequencing
20%
Real-Time Polymerase Chain Reaction
20%
Health Status
20%
Biodiversity
20%
Cyanobacteria
20%
Bacteroidetes
20%
Neuroscience
Longitudinal Study
100%
Amyotrophic Lateral Sclerosis
100%
Placebo
20%
Body Mass Index
20%
Real-Time Polymerase Chain Reaction
20%
DNA 16S
20%
Gel Electrophoresis
20%